Trial: 202103081

Phase 2 Study of FLX475 in Combination with Ipilimumab in Advanced Melanoma

Phase

II

Principal Investigator

Johanns, Tanner

Disease Site

Melanoma, Skin

Learn more about this study at: clinicaltrials.gov